Daisuke Miyashita Selected Research

Daisuke Miyashita Research Topics

3	Type 2 Diabetes Mellitus (MODY) 07/2022 - 01/2020
2	Insulin Resistance 12/2021 - 01/2020
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 12/2009 - 11/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2022
1	Liver Diseases (Liver Disease) 12/2021
1	Central Nervous System Diseases (CNS Diseases) 07/2021
1	Hyponatremia 07/2021
1	Meningitis 07/2021
1	Neoplasms (Cancer) 07/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Atrophy 10/2020
1	Glucose Intolerance 10/2020
1	Inflammation (Inflammations) 10/2020
1	Fatty Liver 10/2020
1	Obesity 01/2020
1	Hantavirus Infections 10/2012
1	Persistent Infection 01/2007
1	Infections 01/2007

4	EnzymesIBA 07/2022 - 12/2009
3	Insulin (Novolin)FDA Link 12/2021 - 10/2020
3	ImmunosorbentsIBA 01/2020 - 12/2009
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2020
2	AntibodiesIBA 12/2009 - 01/2007
1	CalciumIBA 07/2022
1	Uncoupling Protein 2IBA 07/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 07/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021
1	Alanine Transaminase (SGPT)IBA 12/2021
1	XanthineIBA 12/2021
1	Guanosine Triphosphate (GTP)IBA 12/2021
1	Xanthine DehydrogenaseIBA 12/2021
1	HDL CholesterolIBA 12/2021
1	Tolvaptan FDA Link 07/2021
1	Arginine Vasopressin (Argipressin)IBA 07/2021
1	SodiumIBA 07/2021
1	Vasopressins (Vasopressin)IBA 07/2021
1	Nonesterified Fatty Acids (NEFA)IBA 10/2020
1	LinagliptinIBA 10/2020
1	Insulin ReceptorIBA 10/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 10/2020
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Complement Factor D (Factor D)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	AdipokinesIBA 01/2020
1	Nucleocapsid ProteinsIBA 10/2012
1	VaccinesIBA 11/2008
1	RNA (Ribonucleic Acid)IBA 01/2007
1	Viral RNAIBA 01/2007
1	AntigensIBA 01/2007

1	Therapeutics 01/2021